IP Verse

Revance Therapeutics patent opposition analysis

Get Patent Opposition Report for Revance Therapeutics

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Revance Therapeutics opposed by its competitors

Explore Revance Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2490986	Apr 24, 2024	Methods And Systems For Purifying Non-Complexed Botulinum Neurotoxin	1
EP3368071	Jan 26, 2022	Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect	1
EP2661276	Aug 2, 2017	Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions	1

Top competitors of Revance Therapeutics

ALLERGAN

IPSEN BIOPHARMA

WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIG